We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Lipid Parameters and Cardiovascular Events in Patients Taking Statins

Robert D. Brook, MD; Melvyn Rubenfire, MD
JAMA. 2012;308(2):131-133. doi:10.1001/jama.2012.6616.
Text Size: A A A
Published online


To the Editor: Dr Boekholdt and colleagues1 performed a meta-analysis of 8 trials to compare the strengths of the association of levels of apoB, non–HDL-C, and LDL-C while patients were taking statins with risk of future cardiovascular events. The authors should have acknowledged that statins reduced apoB to a lesser extent than lipoproteins, which has been reported before2 and may have contributed to the modest superiority of non–HDL-C, given that HRs per SD change in each factor were evaluated. Due to variations in atherogenic particle cholesterol content, the risks of non–HDL-C and apoB can differ in subsets of individuals even if they are fairly similar for the overall population.3 To address this issue, it would be important to know whether patients with discordantly elevated apoB levels compared with non–HDL-C levels (evaluated by achieved percentiles or threshold targets of apoB) were at residual high cardiovascular risk.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




July 11, 2012
Seth S. Martin, MD; Steven R. Jones, MD
JAMA. 2012;308(2):131-133. doi:10.1001/jama.2012.6614.
July 11, 2012
S. Matthijs Boekholdt, MD, PhD; John J. P. Kastelein, MD, PhD
JAMA. 2012;308(2):131-133. doi:10.1001/jama.2012.6632.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.